TCTR20200604014已完成3 期
Intralesional measles, mumps, rubella (MMR) vaccine versus tuberculin purified protein derivative (PPD) in the treatment of palmoplantar and periungual warts: A randomized controlled trial
Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital0 个研究点目标入组 40 人开始时间: 2020年6月4日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •At least one palmoplantar or periungual wart.
- •Personal history of MMR vaccine
排除标准
- •History of topical treatment of target wart within 2 weeks or other treatment target warts within 4 weeks prior to our study
- •Have fever or other inflammation or infection in any part of body
- •Immunocompromised host, using immunosuppressive drugs, or current radiotherapy
- •Receiving immunoglobulin within 6 weeks
- •pregnant or lactating women
- •currently using anticoagulant drugs
- •Personal history of asthma, severe dermatitis, meningitis, TB, epilepsy
研究者
相似试验
尚未招募
不适用
Protective antibiotic titres for measles, mumps and rubella in children and adolescents with chronic kidney diseaseCTRI/2019/06/019873Maulana Azad medical College
尚未招募
3 期
Effectiveness of Measles, Mumps and Rubella Vaccine in Health Care Professionals for COVID-19PACTR202006883882711Dar Al Fouad Hospital200
尚未招募
2 期
Efficacy of MMR vaccine in wartsCTRI/2018/10/016238self
已完成
不适用
A study to find out the effectiveness of measles, mumps, rubella(mmr) vaccine in the treatment of common warts and to compare its efficacy with formic acid treatment of common warts.CTRI/2017/07/009041Myfanwy Joanne Dsouza60
进行中（未招募）
1 期
Can the measles-mumps-rubella vaccine be given to children already at 6 months of age?Infection with measles, mumps or rubellaMedDRA version: 20.0Level: LLTClassification code 10036654Term: PreventionSystem Organ Class: 100000004865EUCTR2016-001901-18-DKThe Danish National University Hospital Rigshospitalet6,500